Pyxis Oncology Inc
NASDAQ:PYXS
Pyxis Oncology Inc
NASDAQ:PYXS
Price:
1.78
USD
4.09%
Market Closed
Market Cap:
$112.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pyxis Oncology Inc
NASDAQ:PYXS
|
US |
|
E
|
Eversendai Corporation Bhd
KLSE:SENDAI
|
MY |
|
G
|
GM Leather SpA
MIL:GML
|
IT |
|
ATAC Resources Ltd
XTSX:ATC
|
CA |
|
Photronics Inc
NASDAQ:PLAB
|
US |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
|
T
|
Tata Steel Ltd
LSE:TTST
|
IN |
|
Komatsu Ltd
TSE:6301
|
JP |
|
Eagle Eye Solutions Group PLC
LSE:EYE
|
UK |
|
Emerald Resources NL
ASX:EMR
|
AU |
|
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
US |
|
Tutor Perini Corp
NYSE:TPC
|
US |
|
B
|
Brixmor Property Group Inc
F:BXR
|
US |
|
Medistim ASA
OSE:MEDI
|
NO |
|
O
|
Oneflow AB
STO:ONEF
|
SE |
|
C
|
Cecep Costin New Materials Group Ltd
HKEX:2228
|
HK |
Wall St Price Targets
PYXS Price Targets Summary
Pyxis Oncology Inc
Pyxis Oncology Inc
Wall Street analysts forecast PYXS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PYXS is 6.91 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
5.05
USD
184% Upside
Average Forecast
Price Target
6.91
USD
288% Upside
Highest Forecast
Price Target
9.45
USD
431% Upside
Pyxis Oncology Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PYXS's stock price target?
Price Target
6.91
USD
6.91
USD
According to Wall Street analysts, the average 1-year price target for PYXS is 6.91 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Pyxis Oncology Inc?
Projected CAGR
61%
61%
The compound annual growth rate for Revenue over the next 8 years is 61%.
